1. Home
  2. LEXX vs FOSL Comparison

LEXX vs FOSL Comparison

Compare LEXX & FOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • FOSL
  • Stock Information
  • Founded
  • LEXX 2004
  • FOSL 1984
  • Country
  • LEXX Canada
  • FOSL United States
  • Employees
  • LEXX N/A
  • FOSL N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • FOSL Consumer Specialties
  • Sector
  • LEXX Health Care
  • FOSL Consumer Discretionary
  • Exchange
  • LEXX Nasdaq
  • FOSL Nasdaq
  • Market Cap
  • LEXX 49.3M
  • FOSL 55.3M
  • IPO Year
  • LEXX N/A
  • FOSL 1993
  • Fundamental
  • Price
  • LEXX $3.13
  • FOSL $1.26
  • Analyst Decision
  • LEXX Strong Buy
  • FOSL
  • Analyst Count
  • LEXX 2
  • FOSL 0
  • Target Price
  • LEXX $11.00
  • FOSL N/A
  • AVG Volume (30 Days)
  • LEXX 100.1K
  • FOSL 288.6K
  • Earning Date
  • LEXX 11-18-2024
  • FOSL 11-06-2024
  • Dividend Yield
  • LEXX N/A
  • FOSL N/A
  • EPS Growth
  • LEXX N/A
  • FOSL N/A
  • EPS
  • LEXX N/A
  • FOSL N/A
  • Revenue
  • LEXX $411,019.00
  • FOSL $1,280,256,000.00
  • Revenue This Year
  • LEXX $82.02
  • FOSL N/A
  • Revenue Next Year
  • LEXX $95.09
  • FOSL N/A
  • P/E Ratio
  • LEXX N/A
  • FOSL N/A
  • Revenue Growth
  • LEXX 34.05
  • FOSL N/A
  • 52 Week Low
  • LEXX $0.85
  • FOSL $0.75
  • 52 Week High
  • LEXX $6.85
  • FOSL $1.92
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 48.37
  • FOSL 59.27
  • Support Level
  • LEXX $2.91
  • FOSL $1.23
  • Resistance Level
  • LEXX $3.39
  • FOSL $1.10
  • Average True Range (ATR)
  • LEXX 0.19
  • FOSL 0.09
  • MACD
  • LEXX 0.00
  • FOSL 0.02
  • Stochastic Oscillator
  • LEXX 56.02
  • FOSL 81.82

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.

Share on Social Networks: